Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-22-007701
Filing Date
2022-03-30
Accepted
2022-03-30 16:41:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A nby20220324_defa14a.htm DEFA14A 8217
2 c01.jpg GRAPHIC 993344
3 c02.jpg GRAPHIC 856726
  Complete submission text file 0001437749-22-007701.txt   2548434
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33678 | Film No.: 22787097
SIC: 2834 Pharmaceutical Preparations